STOCK TITAN

Major Memphis Health System Expands BVA® Adoption to New Hospital Outpatient Site

(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Daxor (Nasdaq: DXR) announced that a Memphis health system expanded its Blood Volume Analysis program to another hospital campus using Daxor’s ezBVA Lab service.

The expansion builds on existing use within the health system and brings blood volume testing to an outpatient clinic at the additional campus. Daxor’s Oak Ridge, Tennessee, laboratory provides the clinic with blood volume results within 24 hours. Testing is supported by existing reimbursement codes.

Loading...
Loading translation...

Positive

  • Minor pointezBVA Lab adoption expanded to an outpatient clinic at another hospital campus within an existing health system customer.

Negative

  • None.

Key Figures

Turnaround time: 24 hours
Turnaround time
24 hours
Outpatient clinic blood volume testing

Key Terms

blood volume analysis
1 terms
blood volume analysis medical
"expanded its Blood Volume Analysis (BVA) program"
A clinical test that measures how much blood a person has and how it is distributed between plasma and red cells, often using tracers or dyes and mathematical calculations. Think of it like measuring how much water is in different compartments of a tank to understand whether there is too much or too little; this information can affect drug dosing, treatment decisions, clinical trial endpoints, and the market value of diagnostics or therapies tied to fluid-management conditions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

Daxor’s ezBVA Lab Diagnostic Service Delivers 24-hour Turnaround Under Established Reimbursement Pathways to Support Ambulatory Care

Oak Ridge, TN, Nov. 18, 2026 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announced that a major Memphis health system has expanded its Blood Volume Analysis (BVA) program to an additional hospital campus, utilizing Daxor’s ezBVA Lab service to support outpatient clinic testing.

The launch builds on established clinical utilization within the health system, demonstrating how multi-hospital networks can replicate BVA programs across campuses without capital budgets or specialized laboratory buildouts. Utilizing Daxor’s Oak Ridge diagnostic laboratory, the newly onboarded outpatient clinic receives actionable blood volume results within 24 hours, supported by existing reimbursement codes.

“Replicating adoption across multiple facilities within the same health system is a core driver of our commercial expansion,” said Annette Plishka, SVP of Commercialization at Daxor. “Because ezBVA Lab centralizes the analytical workflow in Tennessee, hospitals can bring new outpatient clinic locations online rapidly and cost-effectively. That operational simplicity accelerates our multi-site rollout, scales recurring diagnostic revenue, and equips care teams to manage patients before an acute hospitalization occurs.”

About Daxor Corporation

Daxor Corporation (Nasdaq: DXR) is tackling healthcare's "multi-billion-dollar silent crisis", the inability to precisely measure blood volume. This often results in suboptimal care, prolonged hospital stays, and increased readmissions for many high-cost medical conditions like heart failure and those requiring ICU care. With 50 years of experience and innovation, Daxor is proud to manufacture and distribute its patented, FDA-cleared Blood Volume Analysis (BVA) diagnostic which offers unmatched, real-time, precise data via its rapid, hand-held, lab-based system. This empowers clinicians to make individualized treatment decisions that significantly improve patient outcomes and deliver substantial efficiencies in value-based healthcare. Daxor is ISO certified and operates a U.S.-based, 20,000-square-foot state-of-the-art manufacturing facility, positioning the company for accelerated market expansion.

For more information, please visit our website at Daxor.com.

Sign up to receive news on Daxor’s innovative technology HERE.

Forward-Looking Statements

Certain statements in this release may include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including without limitation statements regarding the impact of hiring sales staff and expansion of our distribution channels. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this release, including, without limitation, those risks associated with our post-market clinical data collection activities, benefits of our products to patients, our expectations with respect to product development and commercialization efforts, our ability to increase market and physician acceptance of our products, potentially competitive product offerings, intellectual property protection, FDA regulatory actions, our ability to integrate acquired businesses, our expectations regarding anticipated synergies with and benefits from acquired businesses, and additional other risks and uncertainties described in our filings with the SEC. Forward-looking statements speak only as of the date when made. Daxor does not assume any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Investor Relations Contact
Bret Shapiro
COO – Head of Capital Markets
COREIR
516-222-2560
brets@coreir.com|www.coreir.com


FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did the Memphis health system expand with Daxor’s ezBVA Lab service?

The health system extended its Blood Volume Analysis program to an outpatient clinic at an additional hospital campus. The clinic uses Daxor’s ezBVA Lab service for testing.

Does Daxor’s ezBVA Lab expansion require the Memphis hospital to build a specialized lab?

Daxor said the service lets hospitals add outpatient testing without building a specialized lab or needing a capital budget. The testing is handled at Daxor’s Oak Ridge laboratory rather than at the new clinic.

Keep reading